Certain clinical trials to be accepted as core R&D activity – draft determination and explanatory statement for consultation

On Thur 20.1.2022, the Government released for consultation the draft Industry Research and Development (clinical trials, Phase 0, I, II, III for an unapproved therapeutic good) Determination 2021. This is relevant for the development of medical products (particularly new products). By way of background, to register for the R&D tax regime, companies must conduct or…

OECD Transfer Pricing Guidelines for Multinational Enterprises and Tax Administrations – guidance on the application of the “arm’s length principle”

20/01/2022 – The OECD released the 2022 edition of the OECD Transfer Pricing Guidelines for Multinational Enterprises and Tax Administrations. The OECD Transfer Pricing Guidelines provide guidance on the application of the “arm’s length principle”, which represents the international consensus on the valuation, for income tax purposes, of cross-border transactions between associated enterprises. In today’s economy…